Viking Therapeutics, Inc.
US ˙ NasdaqCM ˙ US92686J1060

SecurityVKTX / Viking Therapeutics, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership8,486 shares
Latest Disclosed Value $ 219,024
Wolverine Trading, Llc ownership in VKTX / Viking Therapeutics, Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 8,486 shares of Viking Therapeutics, Inc. (US:VKTX) valued at $223,012 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 43,819 shares of Viking Therapeutics, Inc.. This represents a change in shares of -80.63% during the quarter. The current value of the position is $248,894 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (VKTX) in the form of stock options. The firm currently holds call options representing 276,200 of underlying shares valued at $7,128,722 USD and put options representing 109,000 of underlying shares valued at $2,813,290 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VKTX / Viking Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F VIKING THERAPEUTICS COM 92686J106 8,486 -35,333 -80.63 219 -81.15 0.0002
2025-08-18 2025-06-30 13F VIKING THERAPEUTICS COM 92686J106 43,819 -20,276 -31.63 1,162 -29.32 0.0012
2025-05-15 2025-03-31 13F VIKING THERAPEUTICS COM 92686J106 64,095 16,327 34.18 1,644 -13.43 0.0019
2025-02-14 2024-12-31 13F VIKING THERAPEUTICS COM 92686J106 47,768 -7,743 -13.95 1,900 -44.49 0.0018
2024-11-14 2024-09-30 13F VIKING THERAPEUTICS COM 92686J106 55,511 37,462 207.56 3,421 257.85 0.0036
2024-08-14 2024-06-30 13F VIKING THERAPEUTICS COM 92686J106 18,049 -2,925 -13.95 957 -44.39 0.0010
2024-05-15 2024-03-31 13F VIKING THERAPEUTICS COM 92686J106 20,974 9,788 87.50 1,720 726.44 0.0017
2024-02-14 2023-12-31 13F VIKING THERAPEUTICS COM 92686J106 11,186 -28,237 -71.63 208 -52.29 0.0002
2023-11-15 2023-09-30 13F VIKING THERAPEUTICS COM 92686J106 39,423 -112,383 -74.03 436 -81.61 0.0004
2023-08-23 2023-06-30 13F VIKING THERAPEUTICS COM 92686J106 151,806 -12,457 -7.58 2,371 118,450.00 0.0029
2023-05-15 2023-03-31 13F VIKING THERAPEUTICS COM 92686J106 164,263 128,120 354.48 3 -99.41 0.0044
2023-02-14 2022-12-31 13F VIKING THERAPEUTICS COM 92686J106 36,143 36,143 340 0.0005
2022-05-16 2022-03-31 13F VIKING THERAPEUTICS COM 92686J106 0 -16,250 -100.00 0 -100.00
2022-02-14 2021-12-31 13F VIKING THERAPEUTICS COM 92686J106 16,250 16,250 75 0.0001
2020-08-13 2020-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -30,615 -100.00 0 -100.00
2020-05-11 2020-03-31 13F VIKING THERAPEUTICS COM 92686J106 30,615 30,615 145 0.0004
2019-05-15 2019-03-31 13F VIKING THERAPEUTICS COM 92686J106 0 -41,774 -100.00 0 -100.00
2019-02-13 2018-12-31 13F VIKING THERAPEUTICS COM 92686J106 41,774 -26,436 -38.76 316 -73.40 0.0009
2018-11-14 2018-09-30 13F VIKING THERAPEUTICS COM 92686J106 68,210 68,210 1,188 0.0026
2016-11-14 2016-09-30 13F VIKING THERAPEUTICS COM 92686J106 0 -1,336 -100.00 0 -100.00
2016-08-15 2016-06-30 13F VIKING THERAPEUTICS COM 92686J106 1,336 1,336 2 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F VIKING THERAPEUTICS COM Call 276,200 60.96 7,129 56.66 n/a n/a n/a
2025-08-18 2025-06-30 13F VIKING THERAPEUTICS COM Call 171,600 26.36 4,551 30.63 n/a n/a n/a
2025-05-15 2025-03-31 13F VIKING THERAPEUTICS COM Call 135,800 -55.27 3,483 -71.15 n/a n/a n/a
2025-02-14 2024-12-31 13F VIKING THERAPEUTICS COM Call 303,600 56.66 12,074 1.10 n/a n/a n/a
2024-11-14 2024-09-30 13F VIKING THERAPEUTICS COM Call 193,800 83.87 11,944 113.76 n/a n/a n/a
2024-08-14 2024-06-30 13F VIKING THERAPEUTICS COM Call 105,400 -26.75 5,587 -52.65 n/a n/a n/a
2024-05-15 2024-03-31 13F VIKING THERAPEUTICS COM Call 143,900 67.13 11,800 636.52 n/a n/a n/a
2024-02-14 2023-12-31 13F VIKING THERAPEUTICS COM Call 86,100 41.38 1,602 137.69 n/a n/a n/a
2023-11-15 2023-09-30 13F VIKING THERAPEUTICS COM Call 60,900 -46.01 674 -61.73 n/a n/a n/a
2023-08-23 2023-06-30 13F VIKING THERAPEUTICS COM Call 112,800 15.93 1,762 176,000.00 n/a n/a n/a
2023-05-15 2023-03-31 13F VIKING THERAPEUTICS COM Call 97,300 7.40 2 -99.88 n/a n/a n/a
2023-02-14 2022-12-31 13F VIKING THERAPEUTICS COM Call 90,600 852 n/a n/a n/a
2022-11-14 2022-09-30 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F VIKING THERAPEUTICS COM Call 33,500 216.04 93 190.63 n/a n/a n/a
2022-05-16 2022-03-31 13F VIKING THERAPEUTICS COM Call 10,600 -50.00 32 -67.35 n/a n/a n/a
2022-02-14 2021-12-31 13F VIKING THERAPEUTICS COM Call 21,200 98 n/a n/a n/a
2021-11-12 2021-09-30 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-06 2021-06-30 13F VIKING THERAPEUTICS COM Call 19,400 -45.66 120 -44.44 n/a n/a n/a
2021-05-14 2021-03-31 13F VIKING THERAPEUTICS COM Call 35,700 216 n/a n/a n/a
2021-02-12 2020-12-31 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F VIKING THERAPEUTICS COM Call 61,600 -26.40 365 -39.97 n/a n/a n/a
2020-08-13 2020-06-30 13F VIKING THERAPEUTICS COM Call 83,700 11.75 608 71.27 n/a n/a n/a
2020-05-11 2020-03-31 13F VIKING THERAPEUTICS COM Call 74,900 355 n/a n/a n/a
2020-02-12 2019-12-31 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F VIKING THERAPEUTICS COM Call 112,500 781 n/a n/a n/a
2019-05-15 2019-03-31 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F VIKING THERAPEUTICS COM Call 113,500 -17.15 859 -64.01 n/a n/a n/a
2018-11-14 2018-09-30 13F VIKING THERAPEUTICS COM Call 137,000 2,387 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F VIKING THERAPEUTICS COM Put 109,000 0.00 2,813 -2.66 n/a n/a n/a
2025-08-18 2025-06-30 13F VIKING THERAPEUTICS COM Put 109,000 -20.15 2,891 -17.45 n/a n/a n/a
2025-05-15 2025-03-31 13F VIKING THERAPEUTICS COM Put 136,500 11.70 3,501 -27.95 n/a n/a n/a
2025-02-14 2024-12-31 13F VIKING THERAPEUTICS COM Put 122,200 5.98 4,860 -31.61 n/a n/a n/a
2024-11-14 2024-09-30 13F VIKING THERAPEUTICS COM Put 115,300 76.30 7,106 104.99 n/a n/a n/a
2024-08-14 2024-06-30 13F VIKING THERAPEUTICS COM Put 65,400 -24.83 3,467 -51.42 n/a n/a n/a
2024-05-15 2024-03-31 13F VIKING THERAPEUTICS COM Put 87,000 150.00 7,134 1,002.63 n/a n/a n/a
2024-02-14 2023-12-31 13F VIKING THERAPEUTICS COM Put 34,800 83.16 648 208.10 n/a n/a n/a
2023-11-15 2023-09-30 13F VIKING THERAPEUTICS COM Put 19,000 -64.08 210 -74.58 n/a n/a n/a
2023-08-23 2023-06-30 13F VIKING THERAPEUTICS COM Put 52,900 -23.22 826 82,500.00 n/a n/a n/a
2023-05-15 2023-03-31 13F VIKING THERAPEUTICS COM Put 68,900 89.81 1 -99.71 n/a n/a n/a
2023-02-14 2022-12-31 13F VIKING THERAPEUTICS COM Put 36,300 341 n/a n/a n/a
2022-08-15 2022-06-30 13F VIKING THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F VIKING THERAPEUTICS COM Put 12,700 -34.54 39 -56.67 n/a n/a n/a
2022-02-14 2021-12-31 13F VIKING THERAPEUTICS COM Put 19,400 90 n/a n/a n/a
2021-11-12 2021-09-30 13F VIKING THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-06 2021-06-30 13F VIKING THERAPEUTICS COM Put 17,500 1.74 108 3.85 n/a n/a n/a
2021-05-14 2021-03-31 13F VIKING THERAPEUTICS COM Put 17,200 104 n/a n/a n/a
2021-02-12 2020-12-31 13F VIKING THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F VIKING THERAPEUTICS COM Put 22,700 -0.87 135 -18.67 n/a n/a n/a
2020-08-13 2020-06-30 13F VIKING THERAPEUTICS COM Put 22,900 -27.76 166 10.67 n/a n/a n/a
2020-05-11 2020-03-31 13F VIKING THERAPEUTICS COM Put 31,700 150 n/a n/a n/a
2020-02-12 2019-12-31 13F VIKING THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F VIKING THERAPEUTICS COM Put 38,600 268 n/a n/a n/a
2019-05-15 2019-03-31 13F VIKING THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F VIKING THERAPEUTICS COM Put 89,000 -30.25 674 -69.68 n/a n/a n/a
2018-11-14 2018-09-30 13F VIKING THERAPEUTICS COM Put 127,600 2,223 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.